Concepedia

Shreya Vemuri

SV

Statistics

Publications

6

Citations

528

H-Index

6

Active since

2019

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kettering University

Dana-Farber Cancer Institute

Cornell University

National Cancer Institute

Shreya Vemuri is an author at Memorial Sloan Kettering Cancer Center specializing in pathology, hematology, and tumor biology.

Top concepts

Publications per year

2019–2023

6

Publications

6

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation

Eileen M. O’Reilly, Jonathan W. Lee, Mark M. Zalupski et al. · Journal of Clinical Oncology · 2020 · 383 citations · Full text

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma

Anita Kumar, Carla Casulo, Ranjana H. Advani et al. · Journal of Clinical Oncology · 2021 · 55 citations · Full text

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao et al. · Haematologica · 2020 · 42 citations · Full text

Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy

Shivani Handa, Jeong‐Ok Lee, Andriy Derkach et al. · Blood · 2022 · 19 citations · Full text

Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia

Jae H. Park, Sean M. Devlin, Benjamin H. Durham et al. · NEJM Evidence · 2023 · 18 citations · Full text

, , +16

1–5 of 6